Carson Wealth (CWM LLC)’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$290K Buy
11,595
+10,180
+719% +$287K ﹤0.01% 2406
2025
Q4
$45K Buy
1,415
+221
+19% +$7.33K ﹤0.01% 3680
2025
Q3
$43K Sell
1,194
-34
-3% -$1.55K ﹤0.01% 3649
2025
Q2
$71K Buy
1,228
+355
+41% +$20.1K ﹤0.01% 3003
2025
Q1
$51K Buy
873
+358
+70% +$24.4K ﹤0.01% 2978
2024
Q4
$41K Buy
515
+20
+4% +$1.71K ﹤0.01% 2949
2024
Q3
$40K Buy
495
+75
+18% +$5.33K ﹤0.01% 2870
2024
Q2
$26K Buy
420
+18
+4% +$1.07K ﹤0.01% 2949
2024
Q1
$20K Buy
+402
New +$19.1K ﹤0.01% 2918
2023
Q4
Sell
-16
Closed -$1K 4435
2023
Q3
$1K Buy
16
+4
+33% +$136 ﹤0.01% 4049
2023
Q2
$0 Buy
12
+1
+9% +$33 ﹤0.01% 4403
2023
Q1
$0 Hold
11
﹤0.01% 4281
2022
Q4
$0 Hold
11
﹤0.01% 4189
2022
Q3
$0 Hold
11
﹤0.01% 4126
2022
Q2
$0 Buy
+11
New +$400 ﹤0.01% 4039

Other funds holding PRCT

Carson Wealth (CWM LLC)'s PRCT Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Procept Biorobotics (PRCT) stake by 719% in Q1 2026, buying an estimated $287K and bringing the position to 11,595 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #2406.

Carson Wealth (CWM LLC) first reported a position in PRCT in Q2 2022 and has held it in 15 quarters since. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Carson Wealth (CWM LLC) held 11,595 shares of Procept Biorobotics worth $290K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 10,180 Procept Biorobotics shares in Q1 2026, an estimated $287K.
  • Procept Biorobotics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2406 holding.
  • Carson Wealth (CWM LLC) first reported a position in Procept Biorobotics in Q2 2022 and has held it in 15 quarters since.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.